While I couldn't find information about Michael Mrochen specifically as a venture capital partner or investor with Aescuvest, here's a comprehensive overview of his background and activities: **Background and Expertise:** * **Ophthalmology Innovator:** Michael Mrochen is a globally recognized entrepreneur and innovation leader in the field of ophthalmology. He has a 30-year track record of transforming scientific breakthroughs into commercially successful technologies. * **Serial Entrepreneur:** Mrochen has founded, led, and worked with companies that have developed and commercialized multiple innovative ophthalmic technologies and procedures. He is also the founder of IROC Science. * **Technical and Clinical Expertise:** He bridges the technical, clinical, and commercial aspects of the ophthalmic industry. He has experience working with start-ups, medium-sized corporations, and large multinational companies. * **Education:** Mrochen has a background as an Engineer in Physics and holds a Doctor of Theoretical Medicine. * **Academic and Scientific Contributions:** He has lectured at ETH Zurich for 15 years, published over 120 articles, reports, and book chapters in ophthalmology and ophthalmic technology, and holds over 50 patents and patent applications. **Current Roles and Activities:** * **CEO of Allotex:** As of May 2025, Michael Mrochen was appointed as the Chief Executive Officer of Allotex, a biotech and medical device company advancing a natural, biolog
Access investment thesis, focus areas, bio, and contact details for Michael Mrochen and 22,000+ other VC professionals.
Berlin, DE